GO:0010513 positive regulation of phosphatidylinositol biosynthetic process: Signaling Lipid Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010513 describes any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phosphatidylinositol (PtdIns).
• Phosphatidylinositol and its phosphorylated derivatives (phosphoinositides) are central to membrane trafficking, autophagy, ion channel gating and receptor signalling.
• Key regulatory nodes include lipid kinases, phosphatases and their upstream activators that control the flux of PtdIns synthesis at the endoplasmic reticulum and associated membranes.
• Dysregulation of phosphatidylinositol biosynthesis is linked to defects in autophagy, endosomal dynamics, vascular permeability and sensory channel function.
• CRISPR knockout, point-mutation knock-in and overexpression models are essential to dissect causal roles of genes that positively regulate PtdIns biosynthesis.
• Multiplex biosensors and super-resolution imaging now allow direct visualization of phosphoinositide pools in living cells, accelerating mechanistic studies.
Description
Phosphatidylinositol (PtdIns) is a glycerophospholipid that serves as both a structural membrane component and the precursor of all phosphoinositides, a family of signalling lipids that regulate membrane identity, vesicle trafficking, autophagy and ion channel activity. The biological process captured by GO:0010513, positive regulation of phosphatidylinositol biosynthetic process, refers to any mechanism that increases the rate or extent of PtdIns formation. Because PtdIns levels set the substrate pool for phosphatidylinositol kinases and phosphatases, positive regulators of its biosynthesis act as rheostats for diverse phosphoinositide-dependent pathways. Research into GO:0010513 has gained momentum with the realization that phosphoinositide imbalances underlie human pathologies ranging from neurodegeneration and cancer to sensory channelopathies. For example, phosphatidylinositol-3-phosphate (PI3P) is required for autophagosome biogenesis and maturation, and its local production is tightly coupled to the positive regulation of PtdIns biosynthesis. Similarly, TRPV1 and TRPML2 channels are modulated by phosphoinositides, linking PtdIns supply to pain sensation and endosomal vesicle dynamics. For researchers, GO:0010513 provides a conceptual framework to identify and perturb the enzymes, adaptors and upstream signals that drive PtdIns synthesis. This article integrates the QuickGO definition with verified literature to outline the mechanisms, key genes, disease relevance and experimental strategies, including CRISPR-based models and biosensor imaging, that are used to study this process.
positive regulation of phosphatidylinositol biosynthetic process At A Glance
| GO ID | GO:0010513 |
|---|---|
| GO term | positive regulation of phosphatidylinositol biosynthetic process |
| Ontology | biological_process |
| Synonym | none |
| Major function | Increases the rate of phosphatidylinositol formation, thereby expanding the substrate pool for phosphoinositide signalling |
| Related processes | Autophagy membrane dynamics, endosomal vesicle trafficking, receptor signalling, ion channel regulation |
| Key enzymes | PIS, PI4K, PI3K and associated regulatory proteins |
| Cellular location | Endoplasmic reticulum and membrane contact sites where PtdIns synthesis occurs |
| Disease links | Neurodegeneration, cancer, vascular permeability disorders, sensory channelopathies |
What Is GO:0010513?
GO:0010513, positive regulation of phosphatidylinositol biosynthetic process, is a biological process term defined as any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phosphatidylinositol. In practice, this includes activation of enzymes such as CDP-diacylglycerol-inositol 3-phosphatidyltransferase (PIS) and downstream lipid kinases, as well as relief of inhibitory constraints, that together elevate the cellular pool of PtdIns available for phosphoinositide synthesis.
Why Is positive regulation of phosphatidylinositol biosynthetic process Important in Cell Biology?
Positive regulation of phosphatidylinositol biosynthesis is important because PtdIns is the committed precursor for all phosphoinositides, which control some of the most fundamental cellular decisions, including whether a membrane is recognized as autophagic, endosomal or plasma membrane. When this regulation is perturbed, the resulting imbalance in phosphoinositide pools can disrupt autophagy, alter receptor signalling and change the gating of ion channels such as TRPV1 and TRPML2, with direct consequences for human disease.
• PtdIns is the precursor of PI3P, PI4P, PI(4,5)P2 and other phosphoinositides that define organelle identity.
• Positive regulation of PtdIns biosynthesis supports autophagosome formation and maturation.
• Phosphoinositide pools generated from PtdIns regulate endosomal vesicle dynamics via TRPML2.
• PtdIns-derived lipids modulate TRPV1 channel activity, affecting pain and sensory signalling.
• Receptor signalling and negative receptor regulation depend on phosphoinositide turnover.
• Vascular permeability downstream of VEGF involves PLCβ2 and phosphoinositide signalling.
• Dysregulated PtdIns biosynthesis is implicated in cancer and neurodegeneration.
• Biosensors enable direct visualization of phosphoinositide changes in living cells.
• CRISPR models allow causal testing of genes that positively regulate PtdIns biosynthesis.
• Understanding GO:0010513 aids drug target discovery for autophagy and channel-related diseases.
What Happens During positive regulation of phosphatidylinositol biosynthetic process?
Activation of PtdIns synthase and upstream supply
In simple terms: The cell boosts the enzyme that makes phosphatidylinositol and ensures it has enough building blocks.
Positive regulation begins with increased activity or expression of CDP-diacylglycerol-inositol 3-phosphatidyltransferase (PIS), which condenses CDP-diacylglycerol with myo-inositol to form PtdIns. Upstream signals that enhance substrate availability or relieve product inhibition elevate flux through this step, expanding the PtdIns pool.
Coupling to phosphoinositide kinase recruitment
In simple terms: Once phosphatidylinositol is made, it is quickly handed off to kinases that convert it into signalling lipids.
Newly synthesized PtdIns is rapidly phosphorylated by phosphatidylinositol kinases such as PI4K and PI3K to generate PI4P and PI3P. Positive regulation of PtdIns biosynthesis therefore indirectly increases the substrate supply for these kinases, and in some contexts the kinases and their activators are co-regulated with PIS to ensure coordinated phosphoinositide production.
Membrane contact site coordination
In simple terms: Different parts of the cell talk to each other to decide where and when to make more phosphatidylinositol.
PtdIns synthesis occurs primarily at the endoplasmic reticulum, but its products are consumed at other membranes. Positive regulation involves membrane contact sites that transfer lipids and coordinate enzyme activities across organelles, ensuring that PtdIns production matches demand at the plasma membrane, endosomes and autophagosomes.
Feedback and homeostatic control
In simple terms: The cell monitors phosphatidylinositol levels and adjusts production to avoid too much or too little.
Positive regulation is balanced by negative feedback loops. When phosphoinositide levels rise, downstream effectors and phosphatases can dampen PIS activity or redirect flux. This homeostatic control is critical because excessive PtdIns synthesis can disrupt membrane composition and signalling.
Integration with autophagy and vesicle trafficking
In simple terms: Making more phosphatidylinositol helps the cell build and recycle membranes during autophagy and transport.
During autophagy, positive regulation of PtdIns biosynthesis supports the production of PI3P-rich membranes that recruit autophagy effectors. Similarly, endosomal vesicle dynamics depend on PI(3,5)P2 generated from PtdIns, and modulation of TRPML2 by this lipid links PtdIns supply to endosomal function.
Key Genes Involved in GO:0010513 positive regulation of phosphatidylinositol biosynthetic process
The following genes and proteins are experimentally implicated in the positive regulation of phosphatidylinositol biosynthetic process or in downstream phosphoinositide-dependent pathways that report on PtdIns availability.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIS (CDIPT) | Catalyzes the final step of PtdIns synthesis | Core enzyme for positive regulation; target for KO and overexpression studies |
| PI4K | Phosphorylates PtdIns to PI4P | Links PtdIns supply to plasma membrane and Golgi signalling |
| PI3K | Phosphorylates PtdIns to PI3P | Key node in autophagy and endosomal trafficking |
| MTM1 | Phosphatase that dephosphorylates PI3P | Negative regulator; models of phosphoinositide imbalance |
| VPS34 | PI3K complex component for PI3P generation | Autophagy initiation; CRISPR KO models available |
| BECN1 | Autophagy regulator interacting with VPS34 | Links PtdIns biosynthesis to autophagy |
| ATG14 | Autophagy-specific VPS34 adaptor | Determines PI3P pool for autophagosomes |
| TRPV1 | Ion channel modulated by phosphoinositides | Readout of PtdIns-derived lipid changes |
| TRPML2 | Endosomal channel regulated by PI(3,5)P2 | Connects PtdIns supply to vesicle dynamics |
| PLCβ2 | Phospholipase generating IP3 and DAG from PIP2 | VEGF-induced vascular permeability |
| PIP5K | Generates PI(4,5)P2 from PI4P | Amplifies phosphoinositide signalling downstream of PtdIns |
| SAC1 | Phosphatase acting on phosphoinositides | Feedback control of PtdIns-derived lipids |
| OCRL | Phosphatase for PI(4,5)P2 | Models of phosphoinositide-related disease |
| INPP4 | Phosphatase for PI(3,4)P2 | Regulates phosphoinositide turnover |
| FIG4 | PI(3,5)P2 5-phosphatase | Endosomal dynamics and neurodegeneration models |
| PIKfyve | Kinase producing PI(3,5)P2 from PI3P | Endosomal vesicle regulation |
| RAB7 | Endosomal GTPase | Coordinates endosomal phosphoinositide dynamics |
How Is positive regulation of phosphatidylinositol biosynthetic process Regulated?
Positive regulation of phosphatidylinositol biosynthesis is controlled at multiple levels. Transcriptional and post-translational activation of PIS and lipid kinases increases flux, while phosphatases such as MTM1, OCRL and SAC1 provide negative feedback by dephosphorylating phosphoinositides. Membrane contact sites and lipid transfer proteins coordinate enzyme localization, ensuring that PtdIns production is matched to demand at specific organelles. In autophagy, the VPS34 complex with BECN1 and ATG14 is a key downstream effector that consumes PtdIns-derived PI3P, and its activity is coupled to nutrient status. Ion channels such as TRPV1 and TRPML2 are regulated by phosphoinositides, providing feedback from membrane excitability to lipid metabolism. VEGF signalling through PLCβ2 illustrates how extracellular cues can modulate phosphoinositide pools and vascular permeability.
positive regulation of phosphatidylinositol biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTM1 | Neurodegeneration, autophagy defects | Knockout and point-mutation knock-in in neuronal cell lines |
| FIG4 | Endosomal dynamics, neurodegeneration | Knockout in HeLa or SH-SY5Y cells |
| TRPV1 | Pain and sensory channelopathy | Point-mutation knock-in to alter lipid binding |
| TRPML2 | Endosomal vesicle disease | Overexpression and knockout in endosomal reporter lines |
| PLCβ2 | Vascular permeability | Knockout in endothelial cells |
Neurodegeneration and autophagy defects
Impaired positive regulation of PtdIns biosynthesis reduces PI3P availability, which compromises autophagosome formation and maturation. Defects in autophagy membrane dynamics are linked to neurodegenerative conditions, and phosphoinositide phosphatases such as MTM1 and FIG4 are associated with neuronal dysfunction.
Cancer and receptor signalling
Phosphoinositide signalling downstream of PtdIns is frequently rewired in cancer. Negative receptor signalling relies on phosphoinositide turnover, and alterations in PI3K and PLCβ2 pathways can promote tumour growth and vascular permeability.
Sensory channelopathies and pain
TRPV1 channel activity is modulated by phosphatidylinositol via distinct binding sites, and changes in PtdIns-derived lipids can alter pain sensation. Similarly, TRPML2 modulation by PI(3,5)P2 affects endosomal vesicle dynamics, linking PtdIns biosynthesis to endolysosomal disease.
Vascular permeability disorders
PLCβ2 promotes VEGF-induced vascular permeability through phosphoinositide signalling, suggesting that positive regulation of PtdIns biosynthesis may influence oedema and vascular leak in pathological conditions.
From positive regulation of phosphatidylinositol biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PIS reduce PtdIns levels? | CRISPR knockout of CDIPT in HEK293 or HeLa cells |
| Does a specific phosphoinositide-binding site mediate channel regulation? | Point-mutation knock-in of TRPV1 lipid-binding residues |
| Can a tagged PIS reveal localization dynamics? | Knock-in of fluorescent tag at endogenous PIS locus |
| Does overexpression of PI3K increase PI3P and autophagy? | Overexpression of VPS34 complex components |
| Which genes regulate endosomal PI(3,5)P2? | CRISPR library screening with PI(3,5)P2 biosensor |
| Does PLCβ2 knockout affect VEGF permeability? | Knockout in endothelial cell monolayer assays |
How to Study the positive regulation of phosphatidylinositol biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | PtdIns and phosphoinositide species | Quantify changes after gene perturbation |
| Biosensor imaging | Local phosphoinositide pools | Live-cell visualization of PI3P, PI4P, PI(4,5)P2 |
| CRISPR knockout screening | Gene requirement for PtdIns levels | Identify positive regulators |
| RNA-seq | Transcriptional changes in lipid enzymes | Pathway analysis after treatment |
| Autophagy flux assay | Autophagosome formation and degradation | Assess PI3P-dependent autophagy |
| Electrophysiology | TRPV1/TRPML2 channel activity | Test lipid regulation of channels |
| Endosomal trafficking reporter | Vesicle dynamics | Measure PI(3,5)P2 effects |
| Proteomics | Protein interactions with PtdIns effectors | Map regulatory complexes |
Genomic and transcriptomic profiling
RNA-seq and CRISPR screening can identify genes whose loss or gain alters PtdIns biosynthesis. Transcriptional signatures of lipid metabolic enzymes provide candidates for positive regulators.
Lipidomics and phosphoinositide measurement
Mass spectrometry-based lipidomics quantifies PtdIns and its phosphorylated derivatives, while recombinant biosensors enable multiplex and super-resolution imaging of phosphoinositides in living cells.
Imaging and biosensor assays
Genetically encoded biosensors for PI3P, PI4P and PI(4,5)P2 allow real-time monitoring of phosphoinositide changes at specific membranes, revealing where positive regulation occurs.
Functional assays for autophagy and trafficking
Autophagy flux assays, endosomal trafficking reporters and electrophysiology for TRP channels provide functional readouts of PtdIns biosynthesis regulation.
How CRISPR Can Be Used to Study GO:0010513 positive regulation of phosphatidylinositol biosynthetic process
Knockout
CRISPR knockout of CDIPT, PI4K, PI3K or VPS34 components can abolish or reduce PtdIns biosynthesis, providing loss-of-function models to test downstream effects on autophagy, endosomal trafficking and channel function.
Point Mutation
Point-mutation knock-in can disrupt specific lipid-binding sites in effectors such as TRPV1 or catalytic residues in PIS, allowing precise structure-function studies without confounding effects of whole-gene deletion.
Knock-in
Tagged knock-in of PIS or PI3K subunits with fluorescent or affinity tags enables localization and interaction studies at endogenous expression levels, revealing where positive regulation occurs.
Overexpression
Overexpression of positive regulators such as PIS, PI4K or VPS34 complex components increases PtdIns and phosphoinositide pools, providing gain-of-function models to study autophagy induction and membrane dynamics.
How EDITGENE Supports positive regulation of phosphatidylinositol biosynthetic process Research
Researchers studying positive regulation of phosphatidylinositol biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in PtdIns production or merely correlated with phosphoinositide changes. CRISPR-based models, combined with lipid biosensors and functional assays, provide the most direct way to establish causality and to dissect the regulatory network.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of phosphatidylinositol biosynthetic process research.
Frequently Asked Questions About positive regulation of phosphatidylinositol biosynthetic process
What is GO:0010513?
GO:0010513 is the Gene Ontology term for positive regulation of phosphatidylinositol biosynthetic process, defined as any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phosphatidylinositol.
What genes are involved in positive regulation of phosphatidylinositol biosynthetic process?
Key genes include CDIPT (PIS), PI4K, PI3K, VPS34, BECN1, ATG14, MTM1, FIG4 and PIKfyve, which together control PtdIns synthesis and its conversion to signalling phosphoinositides.
Why is phosphatidylinositol biosynthesis important for autophagy?
Phosphatidylinositol is the precursor of PI3P, which is required for autophagosome formation and maturation; positive regulation of its biosynthesis therefore supports autophagy membrane dynamics.
How do phosphoinositides regulate ion channels?
Phosphoinositides such as PI(4,5)P2 and PI(3,5)P2 bind to and modulate channels including TRPV1 and TRPML2, affecting pain sensation and endosomal vesicle dynamics.
What diseases are linked to phosphatidylinositol biosynthesis defects?
Defects have been linked to neurodegeneration, autophagy disorders, cancer, vascular permeability and sensory channelopathies.
How can I study positive regulation of phosphatidylinositol biosynthesis?
Researchers use lipidomics, phosphoinositide biosensors, CRISPR knockout or overexpression models, autophagy flux assays and electrophysiology to measure PtdIns and its downstream effects.
What are the best CRISPR models for PtdIns biosynthesis genes?
Knockout of CDIPT or VPS34, point-mutation knock-in of lipid-binding sites, tagged knock-in of PIS and overexpression of PI3K complex components are commonly used.
Which biosensors detect phosphatidylinositol derivatives?
Recombinant biosensors for PI3P, PI4P and PI(4,5)P2 enable multiplex and super-resolution imaging of phosphoinositides in living cells.
Is phosphatidylinositol biosynthesis regulated by feedback?
Yes, phosphatases such as MTM1, OCRL and SAC1 provide negative feedback that balances positive regulation of PtdIns biosynthesis.
How does VEGF signalling connect to phosphoinositide metabolism?
VEGF-induced vascular permeability involves PLCβ2, which hydrolyzes PIP2 and links phosphoinositide signalling to endothelial barrier function.
Conclusion
GO:0010513, positive regulation of phosphatidylinositol biosynthetic process, is a central node in lipid signalling that controls the supply of PtdIns for phosphoinositide-dependent processes such as autophagy, endosomal trafficking, receptor signalling and ion channel regulation. Understanding its mechanisms requires integrating genetic, biochemical and imaging approaches, with CRISPR models providing causal insight into the roles of PIS, PI3K, VPS34 and their regulators. As biosensors and screening technologies advance, the field is poised to uncover new therapeutic targets for diseases rooted in phosphoinositide imbalance.
References
- 1. Nascimbeni AC et al.. 2017. Phosphatidylinositol-3-phosphate in the regulation of autophagy membrane dynamics.. FEBS J 284(9):1267-1278 PMID: 27973739
- 2. Dikic I et al.. 2003. Negative receptor signalling.. Curr Opin Cell Biol 15(2):128-35 PMID: 12648667
- 3. Maib H et al.. 2024. Recombinant biosensors for multiplex and super-resolution imaging of phosphoinositides.. J Cell Biol 223(6) PMID: 38578646
- 4. Shinoda S et al.. 2024. Electrostatic maturation of the autophagosome.. Autophagy 20(10):2357-2358 PMID: 38950891
- 5. Phoenix KN et al.. 2022. PLCβ2 Promotes VEGF-Induced Vascular Permeability.. Arterioscler Thromb Vasc Biol 42(10):1229-1241 PMID: 35861069
- 6. Rohacs T. 2015. Phosphoinositide regulation of TRPV1 revisited.. Pflugers Arch 467(9):1851-69 PMID: 25754030
- 7. Yazici AT et al.. 2021. Dual regulation of TRPV1 channels by phosphatidylinositol via functionally distinct binding sites.. J Biol Chem 296:100573 PMID: 33766560
- 8. Gu ZQ et al.. 2025. TRPML2 channel modulation by PI(3,5)P₂ and small-molecule agonists controls endosomal vesicle dynamics.. Biomed Pharmacother 189:118350 PMID: 40664038
